Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Squamous Cell Carcinoma of Head and Neck 95Head and Neck Neoplasms 92Nasopharyngeal Carcinoma 35Nasopharyngeal Neoplasms 15Laryngeal Neoplasms 12Oropharyngeal Neoplasms 10Mouth Neoplasms 10Hypopharyngeal Neoplasms 9Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Carcinoma, Squamous Cell 7Neoplasm Metastasis 6Esophageal Neoplasms 6Carcinoma 6Stomach Neoplasms 5Tongue Neoplasms 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 4Laryngeal Diseases 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Salivary Gland Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Thyroid Neoplasms 2Pharyngeal Neoplasms 2

Interventions

Cetuximab 16Cisplatin 15Radiotherapy, Intensity-Modulated 10Radiotherapy 6Docetaxel 6Erlotinib Hydrochloride 5Fluorouracil 4Everolimus 4Carboplatin 4Sorafenib 3Radiation 3Paclitaxel 3Fluorodeoxyglucose F18 3Chemotherapy, Adjuvant 3Biopsy 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Platinum 2Photochemotherapy 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Drug Therapy 2Celecoxib 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Tongue Neoplasms × Fluorouracil × Head & Neck × Clear all
NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00665392 2025-08-01

ECHO-07

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Completed
42 enrolled 24 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT01847326 2024-07-31

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

University of Chicago

Phase 1 Completed
48 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01142414 2012-01-16

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡